Key Takeaways Nyxoah gains FDA clearance for its Genio system to treat moderate to severe sleep apnea.Genio's design delivers bilateral nerve stimulation without implanted batteries.Trial results showed up to 71% median AHI reduction across all sleeping positions.Nyxoah (NYXH) recently received FDA approval for its Genio system, an innovative therapy for moderate to severe Obstructive Sleep Apnea (OSA). Featuring a leadless, battery-free design powered by an upgradable wearable, Genio offers a unique bilate ...